Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.2M 494M |
---|---|---|---|---|---|
Net income 2024 * | -12M -957M | Net income 2025 * | -14M -1.12B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.57
x | P/E ratio 2025 * |
-0.55
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.58% |
Latest transcript on Processa Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 28/03/11 |
Sian Bigora
FOU | Founder | 63 | 28/03/11 |
David Young
FOU | Founder | 71 | 28/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 07/08/23 |
James Neal
BRD | Director/Board Member | 68 | 15/07/22 |
Justin Yorke
CHM | Chairman | 58 | 01/10/17 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |